OB/GYN Clinical Alert – October 1, 2021

October 1, 2021

• Does Music Lower Preoperative Anxiety in Pelvic Reconstructive Surgery Patients?

  Listening to music may lower preoperative anxiety in patients undergoing pelvic reconstructive surgery.

  Read more

• Highlights from the CDC’s Updated 2021 Sexually Transmitted Infections Treatment Guidelines

  The Centers for Disease Control and Prevention updated their sexually transmitted infections treatment guidelines with important considerations for women’s health providers, such as new recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, and Mycoplasma genitalium.

  Read more

• Vaginal Misoprostol vs. Prostaglandin E2 Pessary for Induction of Labor at Term

  In this randomized, noninferiority, clinical trial of pregnant women who underwent induction of labor with misoprostol compared to dinoprostone, the rate of vaginal delivery within 24 hours was higher in the misoprostol group. Maternal satisfaction, assessed by a visual analog scale, also was higher. Although the noninferiority of dinoprostone to misoprostol could not be demonstrated, the clinical risk-to-benefit ratio justifies the use of both drugs.

  Read more

• COVID-19 Vaccination, Pregnancy, Lactation, and Fertility: What Should the OB/GYN Know?

  With the increasing circulation of the Delta variant, it has become critically important for the OB/GYN to discuss COVID-19 vaccination with patients, and, specifically, to address concerns related to pregnancy, lactation, and fertility. This article reviews the most recent guidance from the American College of Obstetricians and Gynecologists, the Society of Maternal-Fetal Medicine, and the American Society for Reproductive Medicine on vaccination in reproductive-age individuals.

  Read more